INTRODUCTION
Type 2 diabetes mellitus is characterized by decreased insulin secretion and insulin sensitivity in varying degrees. [1] [2] [3] [4] In Japanese diabetic patients, impaired insulin secretion is emphasized rather than insulin resistance, 5 but insulin resistance also plays an important role in the deterioration of glucose tolerance. 6, 7 Recent studies have shown that the homeostasis model assessment of insulin resistance (HOMA-IR) in Japanese patients with type 2 diabetes was significantly higher than that for subjects with normal glucose tolerance. 7, 8 The prevalence of metabolic syndrome (MetS), which is characterized by insulin resistance 9 defined by the criteria proposed by a Japanese study group, 10 has reached as much as 45.9%
in male and 28.0% in female Japanese type 2 diabetic patients. 11 Therefore, it is important to consider insulin sensitizers in treating Japanese type 2 diabetics as well as insulin secretagogues.
Insulin sensitizers, such as pioglitazone and metformin, are available, and are expected to improve glycemic control in patients with insulin resistance. However, it has not yet been fully clarified which characteristics in diabetic patients determine the efficiency of insulin sensitizers in each patient.
The euglycemic hyperinsulinemic clamp is regarded as the gold standard technique for measurement of in-vivo insulin action, 12 but it requires sophisticated equipment, several hours of work, and considerable expense to use. By contrast, the insulin tolerance test (ITT) is simpler, easy to perform, and a more practical method than the clamp. The glucose disappearance rate calculated from the ITT (K ITT ) has a close correlation with glucose clamp studies. [13] [14] [15] We hypothesized that we could predict the effectiveness of insulin sensitizers in patients using the results of the ITT. In this study, we retrospectively reviewed consecutive subjects with type 2 diabetes mellitus admitted to Osaka University Hospital, Japan, whose insulin resistance had been evaluated by the ITT. We analyzed the association between the effectiveness of insulin sensitizers and K ITT in these patients.
MATERIALS AND METHODS

Patients
We retrospectively reviewed 360 consecutive subjects with type 2 diabetes mellitus admitted to Osaka University Hospital from 2001 to 2008.
Following admission, all of the patients were treated by diet alone or diet plus insulin for at least 2 weeks, until fasting plasma glucose (FPG) was below 7.0 mmol/L. After FPG reached the target level, insulin resistance was evaluated by the ITT, and 32 patients among them were treated with insulin sensitizers, according to the judgment of physicians. Then, we retrospectively analyzed the clinical characteristics and the glycemic control 6 months after discharge.
Measurements
The ITT was performed after an overnight fast, as previously described. 13 Blood samples were collected every 3 minutes for 15 minutes after intravenous regular insulin injection (0.1 U/kg). 
RESULTS
Insulin Tolerance Test
The ITT was performed in 163 out of 360 patients.
The K ITT of these patients ranged from 0.39%/ min to 8.9%/min, and the median value was 1.56%/min. The body mass index (BMI), waist circumference (WC), and VFA were negatively correlated with K ITT (r=-0.15, P=0.05; r=-0.25, P=0.003; and r=-0.23, P=0.02, respectively) ( Table 1) .
Patient Groups
The patients were divided into two groups 
Clinical Characteristics of the Patients
The clinical characteristics of the patients of the K ITT ≤1.56 group and the K ITT >1.56 group (500-750) mg/day for metformin, and 125
(100-150) mg/day for buformine.
Glycemic Control After Discharge
Glycemic control around the time of discharge and 6 months after discharge are shown in (VFA ≥100, VFA <100) in Japan, the results were the same as above (data not shown).
DISCUSSION
In this study, we have shown the possible usefulness of ITT for selecting patients for There are some study limitations to consider.
First, this is a retrospective study, and we could not discriminate the effect of any medication other than insulin sensitizers, especially insulin, on glycemic control after discharge. However, the ratio of patients using insulin in the K ITT ≤1.56 group with insulin sensitizers was not higher than those of other groups. Similarly, the ratio of patients using treatment other than insulin 
